These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


322 related items for PubMed ID: 12454661

  • 1. Shares in the human genome--the future of patenting DNA.
    Thomas SM, Hopkins MM, Brady M.
    Nat Biotechnol; 2002 Dec; 20(12):1185-8. PubMed ID: 12454661
    [No Abstract] [Full Text] [Related]

  • 2. Impact of gene patenting on R&D and commerce.
    Stott M, Valentine J.
    Nat Biotechnol; 2003 Jul; 21(7):729-31; author reply 731. PubMed ID: 12833081
    [No Abstract] [Full Text] [Related]

  • 3. DNA patenting: the end of an era?
    Hopkins MM, Mahdi S, Patel P, Thomas SM.
    Nat Biotechnol; 2007 Feb; 25(2):185-7. PubMed ID: 17287750
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A nail in the coffin for DNA sequence patents?
    Yamanaka M.
    Nat Biotechnol; 2008 Oct; 26(10):1085-6. PubMed ID: 18846072
    [No Abstract] [Full Text] [Related]

  • 6. Patenting the parts.
    Nat Biotechnol; 2007 Aug; 25(8):822. PubMed ID: 17687343
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Patenting pluripotence: the next battle for stem cell intellectual property.
    Vrtovec KT, Scott CT.
    Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biotech patenting matures.
    Lawrence S.
    Nat Biotechnol; 2004 Oct; 22(10):1202. PubMed ID: 15470446
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. US court case to define EST patentability.
    Lawrence S.
    Nat Biotechnol; 2005 May; 23(5):513. PubMed ID: 15877055
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. EU to review rare disease drugs market exclusivity.
    Sheridan C.
    Nat Biotechnol; 2004 Sep; 22(9):1061. PubMed ID: 15340455
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ownership at too high a price?
    Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.